Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Augustinus Bader

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Artificial Organs|October 10, 2006
Evaluation of liver support systems for preclinical testing by animal trialsOleksandr Seleverstov, Augustinus Bader
Current Stem Cell Research & Therapy|October 27, 2015
Personalized and Regenerative Medicine for Liver DiseasesShibashish Giri, Augustinus Bader
Drug Discovery Today|December 3, 2014
A low-cost, high-quality new drug discovery process using patient-derived induced pluripotent stem cellsShibashish Giri, Augustinus Bader
Journal of Clinical and Experimental Hepatology|March 11, 2015
Shortcut route for generation of functional hepatocyte cells from human skin allogenically for autologous treatment of chronic liver diseasesShibashish Giri, Augustinus Bader
Journal of Clinical and Experimental Hepatology|March 11, 2015
Preclinical Liver Bud Engineering towards Clinical Target for Liver DiseasesShibashish Giri, Augustinus Bader
Journal of Biomolecular Techniques : JBT|June 11, 2004
Quantitative real-time polymerase chain reaction: methodical analysis and mathematical modelStefan Wilkening, Augustinus Bader
Journal of Cellular and Molecular Medicine|April 22, 2010
Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approachAugustinus Bader, Paolo Macchiarini
Advances in Biochemical Engineering/Biotechnology|May 7, 2002
Bioreactor developments for tissue engineering applications by the example of the bioartificial liverInka Jasmund, Augustinus Bader
Journal of Biochemical and Molecular Toxicology|August 5, 2003
Influence of culture time on the expression of drug-metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2Stefan Wilkening, Augustinus Bader
Drug Discovery Today|March 1, 2011
Improved preclinical safety assessment using micro-BAL devices: the potential impact on human discovery and drug attritionShibashish Giri, Augustinus Bader
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Artificial Organs|October 10, 2006
Evaluation of liver support systems for preclinical testing by animal trialsOleksandr Seleverstov, Augustinus Bader
Current Stem Cell Research & Therapy|October 27, 2015
Personalized and Regenerative Medicine for Liver DiseasesShibashish Giri, Augustinus Bader
Drug Discovery Today|December 3, 2014
A low-cost, high-quality new drug discovery process using patient-derived induced pluripotent stem cellsShibashish Giri, Augustinus Bader
Journal of Clinical and Experimental Hepatology|March 11, 2015
Shortcut route for generation of functional hepatocyte cells from human skin allogenically for autologous treatment of chronic liver diseasesShibashish Giri, Augustinus Bader
Journal of Clinical and Experimental Hepatology|March 11, 2015
Preclinical Liver Bud Engineering towards Clinical Target for Liver DiseasesShibashish Giri, Augustinus Bader
Journal of Biomolecular Techniques : JBT|June 11, 2004
Quantitative real-time polymerase chain reaction: methodical analysis and mathematical modelStefan Wilkening, Augustinus Bader
Journal of Cellular and Molecular Medicine|April 22, 2010
Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approachAugustinus Bader, Paolo Macchiarini
Advances in Biochemical Engineering/Biotechnology|May 7, 2002
Bioreactor developments for tissue engineering applications by the example of the bioartificial liverInka Jasmund, Augustinus Bader
Journal of Biochemical and Molecular Toxicology|August 5, 2003
Influence of culture time on the expression of drug-metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2Stefan Wilkening, Augustinus Bader
Drug Discovery Today|March 1, 2011
Improved preclinical safety assessment using micro-BAL devices: the potential impact on human discovery and drug attritionShibashish Giri, Augustinus Bader
Pageof 10